The purpose of SMA Europe is to provide a framework to stimulate collaboration and accelerate translational research pathways in SMA and promote patient care.

  1. SMA Europe bi-annual meeting – October 2017

    SMA Europe is hodling its second annual meeting of the year, kindly hosted by the German neuromuscular disease association, DGM (Deutsche Gesellschaft  für Muskelkranke e.V.) in Berlin between 13th & 14th October 2017.

    The programme will include:

    • Individual meetings with the main pharmaceutical companies involved in the development of therapies for SMA (Avexis, Biogen, Novartis & Roche);
    • A visit from the Ministry of Health;
    • SMA Europe internal meeting.